Ministry of National Health Services, Regulations and Coordination

Drug Regulatory Authority of Pakistan

National Control Laboratory for Biologicals

Home Up DBER About Us Search Contents FAQs

Tetanus Toxoid

All function of NCLB are now under DRAP Act, 2012 (Act No. XXI of 2012) and all previous actions and SROs are protected.

Lot Release is now under Schedule I, and NCLB is part of DRAP under Section 3 of this Act.

For detailed description of various aspects of DRAP Act, 2012 visit this link


DRAP Act, 2012 pdf file. 



Manufactured by NIH Islamabad, and AVP Islamabad WHO TRS
Both manufacturers use concentrate from same manufacturer; the imported concentrate is diluted adsorbed on aluminium base adjuvant and filled in either multidose vials or single dose ampoules. Recommendations for Diphtheria, Tetanus, Pertussis and Combined Vaccines, Amendments 2003
WHO Technical Report Series, No. 927, Annex 5
Both manufacturers work in GMP compliant facilities and test the vaccine according to WHO recommendations. Requirements for Diphtheria, Tetanus, Pertussis and Combined Vaccines
WHO Technical Report Series 800, 1990


Home ] Up ]

Send mail to with questions or comments about this web site.
Copyright 2011 National Control Laboratory for Biologicals
Last modified: 17-Mar-2015